Concepedia

David F. Nippa

DF

Statistics

Publications

5

Citations

202

H-Index

5

Active since

2022

Affiliations

Ludwig-Maximilians-Universität München(Current)

Roche (Switzerland)

ETH Zurich

David F. Nippa is an author at Ludwig-Maximilians-Universität München specializing in drug discovery, medicinal chemistry, and pharmacy.

ORCID

Publications per year

2022–2024

5

Publications

5

Prospective de novo drug design with deep interactome learning

Kenneth Atz, Leandro Cotos, Clemens Isert et al. · Nature Communications · 2024 · 77 citations · Full text

, , +17

Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning

David F. Nippa, Kenneth Atz, Remo Hohler et al. · Nature Chemistry · 2023 · 75 citations · Full text

, , +15

Late-stage Functionalization and its Impact on Modern Drug Discovery

David F. Nippa, Remo Hohler, Antonia F. Stepan et al. · CHIMIA International Journal for Chemistry · 2022 · 23 citations · Full text

, , +14

Identifying opportunities for late-stage C-H alkylation with high-throughput experimentation and in silico reaction screening

David F. Nippa, Kenneth Atz, Alex T. Müller et al. · Communications Chemistry · 2023 · 16 citations · Full text

, , +17

Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning

David F. Nippa, Kenneth Atz, Remo Hohler et al. · ChemRxiv · 2022 · 11 citations · Full text

, , +15

1–5 of 5